A Non-Randomized Concurrent Controlled Trial of Myofunctional Treatment in the Mixed Dentition Children with Functional Mouth Breathing Assessed by Cephalometric Radiographs and Study Models
Habumugisha Janvier,Cheng Bo,Ma Shu-Yu,Zhao Min-Yue,Bu Wen-Qing,Wang Gao-Li,Liu Qiong,Zou Rui,Wang Fei
DOI: https://doi.org/10.1186/s12887-022-03559-w
2022-01-01
BMC Pediatrics
Abstract:Objectives This study aimed to examine the clinical effects of myofunctional treatment on children with functional mouth breathing by cephalometric radiographs and study models. Methods A total of 224 children (6–10 years old; 114 males and 110 females; SNA°: 82.24 ± 1.67°; ANB°: 2.79 ± 0.80°, 28° < SN-GoGn° < 37°) formed three groups: MB-M group (mouth breathers with myofunctional treatment, n = 75); MB-N group (mouth breathers with no treatment, n = 70); NB group (nasal breathers with no treatment, n = 79). A blind evaluation of cephalometric radiographs and study models was conducted at T1(pre-study) and T2 (post-study), respectively. Results Two hundred four children (MB-M:66, MB-N:68, NB:70) completed the present study. At T1, MB-M and MB-N groups, compared to their NB counterpart, had greater anterior lower facial height( P < 0.01) and overjet( P < 0.001) but shorter overbite and maxillary canines width ( P < 0.001). At T2, the MB-N group exhibited a higher ANB angle, anterior lower facial height, and overjet, but shorter overbite and maxillary canines width ( P < 0.001). From T1 to T2, the anterior lower facial height increased, overbite and the maxillary canines width further decreased in the MB-N group ( P < 0.001). However, in the MB-M group, the incisors were retracted, overbite increased ( P < 0.001), anterior lower facial height increased insignificantly ( P > 0.05), and maxillary canines width increased slightly ( P < 0.05). In the NB and MB-M groups, the mandible showed a normal tendency to grow forward, whereas, in the MB-N group, the mandible showed a tendency to grow downward ( P < 0.001). Conclusions Mouth breathers demonstrated increased anterior facial height and overjet but reduced overbite and maxillary arch width, which improved significantly following myofunctional treatment. Trial registration TCTR: TCTR20220401001 . Registered 1 st April 2022-Retrospectively registered.